Roundhill Investments Launches GLP-1 & Weight Loss ETF
Portfolio Pulse from Benzinga Newsdesk
Roundhill Investments has launched the Roundhill GLP-1 & Weight Loss ETF (OZEM), which focuses on the growing weight loss management market. The ETF began trading on Nasdaq and targets the GLP-1 receptor agonists and weight management drugs sector.
May 21, 2024 | 1:42 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Roundhill Investments has launched the Roundhill GLP-1 & Weight Loss ETF (OZEM), which focuses on the growing weight loss management market. The ETF began trading on Nasdaq and targets the GLP-1 receptor agonists and weight management drugs sector.
The launch of OZEM on Nasdaq provides investors with a new opportunity to gain exposure to the rapidly growing weight loss management market, which is expected to reach $100 billion by 2030. This could attract significant investor interest and drive up the ETF's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100